Interferon Gamma Release Assays for the Diagnosis of Latent TB Infection in HIV-Infected Individuals in a Low TB Burden Country

PLoS ONE

Volumn 8, Issue 1, 2013, Pages

  Ní Cheallaigh, Clíona ^a   Fitzgerald, Ian ^a   Grace, Jacinta ^a   Jagjit Singh, Gurmit ^a   El Eraki, Nahla ^a   Gibbons, Noel ^a   Keane, Joseph ^a   Rogers, Thomas R ^a   Clarke, Susan ^a   Bergin, Colm ^a  

^a ST JAMES S HOSPITAL   (Ireland)

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ADULT; AGED; ARTICLE; CD4 LYMPHOCYTE COUNT; CONTROLLED STUDY; DIAGNOSTIC TEST ACCURACY STUDY; FEMALE; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFECTION RISK; INTERFERON GAMMA RELEASE ASSAY; INTERMETHOD COMPARISON; IRELAND; LATENT TUBERCULOSIS; MAJOR CLINICAL STUDY; MALE; PREVALENCE; RISK ASSESSMENT; SENSITIVITY AND SPECIFICITY; TUBERCULIN TEST; VIREMIA; VIRUS LOAD;

ADULT; AGED; CD4 LYMPHOCYTE COUNT; CD4-POSITIVE T-LYMPHOCYTES; FEMALE; HIV; HIV INFECTIONS; HUMANS; INTERFERON-GAMMA; INTERFERON-GAMMA RELEASE TESTS; LATENT TUBERCULOSIS; MALE; MIDDLE AGED; PREVALENCE; TUBERCULIN TEST;

EID: 84873812985     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0053330     Document Type: Article

References (39)

1. Raviglione MC, Harries AD, Msiska R, Wilkinson D, Nunn P (1997) Tuberculosis and HIV: current status in Africa. AIDS 11 Suppl B: S115-123.
2. Horsburgh CR Jr, O'Donnell M, Chamblee S, Moreland JL, Johnson J, et al. (2010) Revisiting Rates of Reactivation Tuberculosis: A Population-based Approach. Am J Respir Crit Care Med 182: 420-425.
3. Komati S, Shaw PA, Stubbs N, Mathibedi MJ, Malan L, et al. (2010) Tuberculosis risk factors and mortality for HIV-infected persons receiving antiretroviral therapy in South Africa. AIDS 24: 1849-1855.
4. Selwyn P, Hartel D, Lewis V, Schoenbaum E, Vermund S, et al. (1989) A prospective study of the risk of tuberculosis among intravenous drug users with human immunodeficiency virus infection. N Engl J Med 320: 545-550.
5. Holmes CB, Wood R, Badri M, Zilber S, Wang B, et al. (2006) CD4 decline and incidence of opportunistic infections in Cape Town, South Africa: implications for prophylaxis and treatment. J Acquir Immune Defic Syndr 42: 464-469.
6. Christopher A, Ifedayo A, Sasha S, Jimmy V (2010) Treatment of latent tuberculosis infection in HIV infected persons. Cochrane Database of Systematic Reviews Reviews 2010.
7. Elzi L, Schlegel M, Weber R, Hirschel B, Cavassini M, et al. (2007) Reducing Tuberculosis Incidence by Tuberculin Skin Testing, Preventive Treatment, and Antiretroviral Therapy in an Area of Low Tuberculosis Transmission. Clinical Infectious Diseases 44: 94-102.
8. Golub JE, Pronyk P, Mohapi L, Thsabangu N, Moshabela M, et al. (2009) Isoniazid preventive therapy, HAART and tuberculosis risk in HIV-infected adults in South Africa: a prospective cohort. AIDS 23: 631-636.
9. Golub JE, Astemborski J, Ahmed M, Cronin W, Mehta SH, et al. (2008) Long-term effectiveness of diagnosing and treating latent tuberculosis infection in a cohort of HIV-infected and at-risk injection drug users. J Acquir Immune Defic Syndr 49: 532-537.
10. Caiaffa WT, Graham NMH, Galai N, Rizzo RT, Nelson KE, et al. (1995) Instability of Delayed-type Hypersensitivity Skin Test Anergy in Human Immunodeficiency Virus Infection. Arch Intern Med 155: 2111-2117.
11. Laurie ED, Alison ME, Richard JH, Subhash KH, George T, et al. (1995) Tuberculin sensitivity and HIV-1 status of patients attending a sexually transmitted diseases clinic in Lusaka, Zambia: a cross-sectional study. Transactions of the Royal Society of Tropical Medicine and Hygiene 89: 37-40.
12. Chaisson RE, Keruly JC, McAvinue S, Gallant JE, Moore RD, (1996) Effects of an Incentive and Education Program on Return Rates for PPD Test Reading in Patients with HIV Infection. JAIDS Journal of Acquired Immune Deficiency Syndromes 11: 455-459.
13. Andersen P, Munk ME, Pollock JM, Doherty TM, (2000) Specific immune-based diagnosis of tuberculosis. Lancet 356: 1099-1104.
14. Rangaka M, Diwakar L, Seldon R, van Cutsem G, Meintjes G, et al. (2007) Clinical, immunological, and epidemiological importance of antituberculosis T cell responses in HIV-infected Africans. Clin Infect Dis 44: 1639-1646.
15. Wilkinson K, Seldon R, Meintjes G, Rangaka M, Hanekom W, et al. (2009) Dissection of regenerating T-Cell responses against tuberculosis in HIV-infected adults sensitized by Mycobacterium tuberculosis. Am J Respir Crit Care Med 180: 674-683.
16. Kaplan JE, Benson C, Holmes KH, Brooks JT, Pau A, et al. (2009) Guidelines for prevention and treatment of opportunistic infections in HIV-infected adults and adolescents: recommendations from CDC, the National Institutes of Health, and the HIV Medicine Association of the Infectious Diseases Society of America. MMWR Recomm Rep 58(RR-4): 1-207.
17. Leidl L, Mayanja-Kizza H, Sotgiu G, Baseke J, Ernst M, et al. (2010) Relationship of immunodiagnostic assays for tuberculosis and numbers of circulating CD4+ T-cells in HIV infection. Eur Respir J 35: 619-626.
18. Rangaka MX, Wilkinson KA, Seldon R, Van Cutsem G, Meintjes GA, et al. (2007) Effect of HIV-1 Infection on T-Cell-based and Skin Test Detection of Tuberculosis Infection. Am J Respir Crit Care Med 175: 514-520.
19. Stephan C, Wolf T, Goetsch U, Bellinger O, Nisius G, et al. (2008) Comparing QuantiFERON-tuberculosis gold, T-SPOT tuberculosis and tuberculin skin test in HIV-infected individuals from a low prevalence tuberculosis country. AIDS 22: 2471-2479 2410.1097/QAD.2470b2013e3283188415.
20. Elzi L, Steffen I, Furrer H, Fehr J, Cavassini M, et al. (2011) Improved sensitivity of an interferon-gamma release assay (T-SPOT.TB) in combination with tuberculin skin test for the diagnosis of latent tuberculosis in the presence of HIV co-infection. BMC Infect Dis 11: 319.
21. Talati N, Seybold U, Humphrey B, Aina A, Tapia J, et al. (2009) Poor concordance between interferon-gamma release assays and tuberculin skin tests in diagnosis of latent tuberculosis infection among HIV-infected individuals. BMC Infect Dis 9: 15.
22. Cattamanchi A, Davis JL, Worodria W, den Boon S, Yoo S, et al. (2009) Sensitivity and specificity of fluorescence microscopy for diagnosing pulmonary tuberculosis in a high HIV prevalence setting. Int J Tuberc Lung Dis 13: 1130-1136.
23. Santin M, Muñoz L, Rigau D, (2012) Interferon-gamma release assays for the diagnosis of tuberculosis and tuberculosis infection in HIV-infected adults: a systematic review and meta-analysis. PLoS One 7: e32482.
24. Health Protection Surveillance Centre (2009) Report on the Epidemiology of Tuberculosis in Ireland 2007.
25. World Health Organisation (2011) Tuberculosis Country Profiles. Available: http://wwwwhoint/tb/country/data/profiles/en. Accessed: 1 January 2011.
26. Oxford Immunotec (2010) T-Spot TB package insert. Available: http://wwwoxfordimmunoteccom/96-UK. Accesses: 1, August 2010.
27. Quantiferon (2011) Quantiferon-CMI Package Insert. Available: http://wwwcellestiscom/IRM/content/pdf/QFTPI_Englishpdf. Accessed: 1, March 2011.
28. Cattamanchi A, Smith R, Steingart KR, Metcalfe JZ, Date A, et al. (2011) Interferon-gamma release assays for the diagnosis of latent tuberculosis infection in HIV-infected individuals: a systematic review and meta-analysis. J Acquir Immune Defic Syndr 56: 230-238.
29. Stephan C, Wolf T, Goetsch U, Bellinger O, Nisius G, et al. (2008) Comparing QuantiFERON-tuberculosis gold, T-SPOT tuberculosis and tuberculin skin test in HIV-infected individuals from a low prevalence tuberculosis country. AIDS 22: 2471-2479.
30. Vincenti D, Carrara S, Butera O, Bizzoni F, Casetti R, et al. (2007) Response to region of difference 1 (RD1) epitopes in human immunodeficiency virus (HIV)-infected individuals enrolled with suspected active tuberculosis: a pilot study. Clin Exp Immunol 150: 91-98.
31. Brock I, Ruhwald M, Lundgren B, Westh H, Mathiesen L, et al. (2006) Latent tuberculosis in HIV positive, diagnosed by the M. tuberculosis specific interferon-gamma test. Respir Res 7: 56.
32. Luetkemeyer A, Charlebois E, Flores L, Bangsberg D, Deeks S, et al. (2007) Comparison of an interferon-gamma release assay with tuberculin skin testing in HIV-infected individuals. Am J Respir Crit Care Med 175: 737-742.
33. Aichelburg Maximilian C, Rieger A, Breitenecker F, Pfistershammer K, Tittes J, et al. (2009) Detection and Prediction of Active Tuberculosis Disease by a Whole-Blood Interferon-γ Release Assay in HIV-1-Infected Individuals. Clinical Infectious Diseases 48: 954-962.
34. Elliott JH, Vohith K, Saramony S, Savuth C, Dara C, et al. (2009) Immunopathogenesis and diagnosis of tuberculosis and tuberculosis-associated immune reconstitution inflammatory syndrome during early antiretroviral therapy. J Infect Dis 200: 1736-1745.
35. Lee S, Lin H-H, Tsai H-C, Ni Y-Y, Chen Y-S, et al. (2012) Positive predictive value of Interferon-gamma release assay for incident active tuberculosis in HIV-infected persons. Retrovirology 9: P133.
36. Clark SA, Martin SL, Pozniak A, Steel A, Ward B, et al. (2007) Tuberculosis antigen-specific immune responses can be detected using enzyme-linked immunospot technology in human immunodeficiency virus (HIV)-1 patients with advanced disease. Clin Exp Immunol 150: 238-244.
37. Vanini V, Petruccioli E, Gioia C, Cuzzi G, Orchi N, et al. (2012) IP-10 is an additional marker for tuberculosis (TB) detection in HIV-infected persons in a low-TB endemic country. J Infect 65: 49-59.
38. Goletti D, Raja A, Syed Ahamed Kabeer B, Rodrigues C, Sodha A, et al. (2010) Is IP-10 an accurate marker for detecting M. tuberculosis-specific response in HIV-infected persons? PLoS One 5: e12577.
39. Aabye MG, Ruhwald M, Praygod G, Jeremiah K, Faurholt-Jepsen M, et al. (2010) Potential of interferon-gamma-inducible protein 10 in improving tuberculosis diagnosis in HIV-infected patients. Eur Respir J 36: 1488-1490.